Stay updated on Topical BMX-010 in Skin Diseases Clinical Trial
Sign up to get notified when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.

Latest updates to the Topical BMX-010 in Skin Diseases Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 error.SummaryDifference0.2%

- Check11 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check38 days agoChange DetectedRemoved the 403 Forbidden page content and the Home link, returning the view to the normal study details page. The change restores access to the study details as intended.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating access is blocked. This replaces the previous study record content and navigation for the NCT03381625 entry with a standard error page.SummaryDifference17%

Stay in the know with updates to Topical BMX-010 in Skin Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.